Efficacy and safety of oral upadacitinib monotherapy in patients with recalcitrant vitiligo

Published: 24 July 2023| Version 1 | DOI: 10.17632/5y2pj9y2bc.1
Contributors:
Xinhong Su, Ting Gong, Chao Ji, Shi-fan Ruan, Renwei Luo, Qingmei Zhong

Description

Mendeley supplemental figure 1. Patients 1 and 10 before and after 8 and 16 weeks of treatment

Files

Institutions

First Affiliated Hospital of Fujian Medical University

Categories

Vitiligo

Licence